Skip to content

Medical Information Search

This tool is designed to help US Healthcare Professionals search for medical information regarding our company products.

The medical information document(s) may contain information about doses, uses, formulations and populations different from FDA-approved product labeling or contain information about uses not approved by the FDA. This information is provided in response to unsolicited medical inquiry and it is for educational and scientific-exchange purposes only.

hands typing on a laptop browsing acadia.com

Please select a product to search Acadia Medical Information. All fields are required.

Select a Product To Get Started

To get the best results, follow these steps:

  1. Select a product: Choose from the list to start your search.
  2. Enter your search terms: Type what medical information you're looking for in the search bar.
Your Results
Not what you’re looking for?
NUPLAZID® (pimavanserin)
See Full Prescribing Information including BOXED WARNING
DAYBUE (trofinetide)
We couldn’t find any results for your search.

Need more help? Use our Medical Science Liaison (MSL) search to speak to an expert about your specific question related to our products.

If you can’t find what you’re looking for, submit your medical inquiry related to Acadia products.

[template]
AEs in Clinical Trials
Carbohydrate Content
Clinical Development Program in Rett Syndrome
Clinical trials in males
Concomitant Medications in LAVENDER
DAFFODIL: Results
Diarrhea AEs in Clinical Trials
Drug-Drug Interactions
Efficacy Scales in the Lavender Study
Impact of Dosing Below Product Label Recommendations on Treatment Outcomes
Impact of Up-Titration During Treatment Initiation on Tolerability
Impact on Seizures
Long-Term Use
Lotus Study: Questionnaires Used
Management Of Diarrhea Adverse Events
Management of Vomiting Adverse Events
Possible Mechanism of Action
Results from Phase 3 LAVENDER
Results from the LOTUS Study
Taste Management
Up-Titration of Dose During Treatment Initiation
Use in Female RTT Patients Older than Twenty
Vomiting AEs in Clinical Trials
Administration through a nasogastric tube
Clinical Development Program for PD Psychosis
Clinical trial and post-marketing mortality events in psychosis in parkinson's disease
Clinical trials in dementia-related psychosis
Concomitant use of atypical antipsychotics with Nuplazid in PDP
Discontinuation
Doses above 34 mg
Drug-drug interactions
Effect of crushing tablets
Effect on QT interval
Effects of motor function in PDP
Efficacy & safety in parkinson's disease psychosis
Falls & fractures
Hallucination adverse events in PDP
Outcomes from the HARMONY Study in Participants with Parkinson’s Disease Dementia and Dementia with Lewy Bodies
Pimavanserin clinical trials in MDD
Proposed mechanism of action
SAPS-PD individual domains in PDP pivotal study
Sleep effects in PDP
Switching from other antipsychotics in PDP
Temperature excursion
Use in Hepatic Impairment
Use in Renal impairment
Contact an MSL

Use our Medical Science Liaison (MSL) search to speak to an expert about your specific question related to our products

Get in Touch
Request Medical Information

To submit your medical inquiry related to Acadia products, please complete our Medical Information Request Form.

Request Information
This page is intended as an educational resource for U.S. healthcare professionals. Medical Information resources provided may contain information about doses, uses, formulations and populations different from product labelling or contain information about investigational compounds or uses not approved by the FDA.

To report an Adverse Event or Product Complaint please call (844) 422-2342.

Important Note

This page is intended as an educational resource for U.S. healthcare professionals. Medical Information resources provided may contain information about doses, uses, formulations and populations different from product labelling or contain information about investigational compounds or uses not approved by the FDA.


I certify that I am a licensed health care provider in the U.S.

Important Note

You are now being redirected

You are now leaving acadia.com

You are about to leave acadia.com. You will be redirected to a third party website not affiliated with Acadia Pharmaceuticals Inc.
Do you want to continue?

You are leaving our {{LEAVING_REGION}} website and going to our {{ENTERING_REGION}} website, which is in {{ENTERING_LANGUAGE}}.
The information you are about to be referred to may not comply with the local regulatory requirements.
Do you want to continue?

You are now being directed to another Acadia website that contains information about specific treatment(s).
Do you want to continue?

Continue